• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

LifeMine Therapeutics combines AI, drug discovery & microbes with $55m launch

September 18, 2017 By Sarah Faulkner

microbeBacked by the likes of Google and Merck (NYSE:MRK), Cambridge, Mass.-based LifeMine Therapeutics launched today by closing a $55 million Series A round.

The company calls itself the first to “massively scale the genomic discovery of powerful new drugs from eukaryotic microbes”. LifeMine plans to use artificial intelligence to hunt down drugs hidden within the DNA of fungi.

The Series A round was led by WuXi Healthcare Ventures, which includes investors like Foresite Capital, Arch Ventures, Boyu Capital and others.

“My life’s passion has been to discover new treatments that address formidable challenges holding back modern medicine and for major, complex diseases,” co-founder, president & CEO Gregory Verdine said in prepared remarks. “The fungal biosphere is full of answers to these outstanding questions in the form of powerful, bioactive small molecules that engage human targets not previously targeted by conventional drugs. Despite their promise, these fundamentally innovative medicines proved difficult and time-consuming to discover by traditional means, leaving the industry in search of a technological solution.”

“Our genomically-enabled drug discovery engine is precisely that solution, dramatically accelerating the search for nature’s breakthrough drugs. LifeMine has already begun to deliver a pipeline of medicines that promise to profoundly impact human health.”

In connection with the round, LifeMine appointed to its board of directors Edward Hu, WuXi Healthcare Ventures’ founding partner; James Tananbaum, founder & CEO of Foresite Capital; Krishna Yeshwant, general partner at GV; Yanling Cao, managing director of Boyu Capital; and Rick Klausner, the founder and director of Juno Therapeutics, GRAIL, and Mindstrong.

“LifeMine has figured out how to tap into the power of evolution and accelerate the creation of new drugs that meet the greatest medical challenges of our day and those that have frustrated industry-wide attempts at solution,” Hu said. “LifeMine is building an exciting company with the potential to dramatically improve human health and well-being by mining fungi to discover drugs that hit difficult targets. We are proud to have worked with the founders to launch the company and the investor syndicate that came together in this financing round will continue to aggressively support LifeMine’s efforts.”

“LifeMine has the potential to eradicate diseases that were previously thought untreatable by current drug discovery technologies,” Klausner added. “I’m thrilled to be part of the team that will help guide LifeMine as it rapidly brings forward new treatments for some of the most complicated, insufferable diseases.”

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Discovery, Featured, Funding Roundup, Pharmaceuticals, Wall Street Beat Tagged With: Google, lifeminetherapeutics, Merck

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS